LENZ THERAPEUTICS, INC. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
LENZ THERAPEUTICS, INC. (LENZ) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2026-06-30 was $0.00.
- LENZ THERAPEUTICS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2026-03-31 was $0.00.
- LENZ THERAPEUTICS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2025-09-30 was $0.00.
- LENZ THERAPEUTICS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2025-06-30 was $0.00.
- LENZ THERAPEUTICS, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2024 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | $400.00K 10-Q · filed 2026-08-11 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |